Literature DB >> 16859052

Transmission of Mycoba cterium tuberculosis to households of tuberculosis patients: a comprehensive contact tracing study.

Soheila Khalilzadeh1, Heidar Masjedi, Mostafa Hosseini, Arash Safavi, Mohammad-Reza Masjedi.   

Abstract

BACKGROUND: Tuberculosis (TB) continues to be a major health problem in developing countries. Contact investigation is the most appropriate strategy to interrupt transmission and subsequent development of TB.
METHODS: This cross-sectional study was conducted to assess the impact of contact screening on case-finding by using tuberculin skin test chest radiography. Contacts of smear-positive patients with pulmonary TB (index cases) were diagnosed and registered in our center during 2002 - 2004. Contacts, defined as household members living with index cases for >30 days, were screened by sputum examination, tuberculin skin test, and chest radiography.
RESULTS: Sixty-eight patients with smear-positive pulmonary TB were considered as index cases. A total of 224 close contacts with index cases (an average of 3 contacts for each index case) were detected. Age among contacts ranged from 6 months to 74 years. Eighty-three percent of contacts were Iranians and 17% were Afghans. Abnormal radiographs were seen in 49.6% of contacts. Sixteen point five percent of contacts had a positive tuberculin skin test of >10 mm; 7.6% had a positive sputum smear. The mean +/- SD age of Iranian contacts (29.1 +/- 16.6 years) was significantly (P < 0.001) higher than that of Afghans (18.6 +/- 14.1 years). Cavitary formation, nodular pattern, and infiltration were found to have a strong association with a positive sputum smear for acid fast bacilli (100%, 100%, and 87%, respectively).
CONCLUSION: The rate of TB in contacts was higher than other similar studies. Earlier detection and treatment of adults with TB could interrupt transmission and be a step towards eliminating childhood TB. Contact control and source-case investigations should be emphasized for TB control. Novel strategies are needed to maximize the number of contacts who are not only identified and evaluated, but also completely treated.

Entities:  

Mesh:

Year:  2006        PMID: 16859052

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  6 in total

1.  Immunotherapeutic effects of recombinant adenovirus encoding granulocyte-macrophage colony-stimulating factor in experimental pulmonary tuberculosis.

Authors:  A Francisco-Cruz; D Mata-Espinosa; S Estrada-Parra; Z Xing; R Hernández-Pando
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

Review 2.  Contact investigation for tuberculosis: a systematic review and meta-analysis.

Authors:  Gregory J Fox; Simone E Barry; Warwick J Britton; Guy B Marks
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

3.  The prevalence of latent tuberculosis infection and smear positive pulmonary tuberculosis in people with household close contact with tuberculosis in north of iran.

Authors:  Mahmood Moosazadeh; Narges Khanjani; Mohammadreza Parsaee
Journal:  Iran J Med Sci       Date:  2015-03

4.  Household contact investigation for the detection of active tuberculosis and latent tuberculosis: A comprehensive evaluation in two high-burden provinces in Iran.

Authors:  R M Ghanaiee; A Karimi; S M Hoseini-Alfatemi; J A Seddon; M Nasehi; P Tabarsi; S A Fahimzad; S Armin; J Akbarizadeh; E Rahimarbabi; L Azimi
Journal:  New Microbes New Infect       Date:  2022-01-17

5.  Estimating the extent of household contact misclassification with index cases of disease in longitudinal studies using a stochastic simulation model.

Authors:  Tobias Chirwa; Sian Floyd; Paul Fine
Journal:  Glob Health Action       Date:  2013-01-24       Impact factor: 2.640

6.  Prevention of tuberculosis in household members: estimates of children eligible for treatment.

Authors:  Yohhei Hamada; Philippe Glaziou; Charalambos Sismanidis; Haileyesus Getahun
Journal:  Bull World Health Organ       Date:  2019-05-28       Impact factor: 9.408

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.